Publications by authors named "Kate Mulryan"

Claim this Profile
R
Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy.
Fernanda V Castro, Mariam Al-Muftah, Kate Mulryan, Hui-Rong Jiang, Jan-Wouter Drijfhout

Cancer Immunol Immunother· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAC2, AEP, and ICAM1 expression are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia.
Mark Holland, Fernanda V Castro, Seema Alexander, Duncan Smith, Jizhong Liu, Kate Mulryan

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen.
Sumia Ali, Kate Mulryan, Taher Taher, Peter L Stern

Cancer Immunol Immunother· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of vaccination and chimeric receptor expressing T cells provides improved active therapy of tumors.
Hui-Rong Jiang, David E Gilham, Kate Mulryan, Natalia Kirillova, Robert E Hawkins

J Immunol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy.
Katie L Green, Tom D Southgate, Kate Mulryan, Lez J Fairbairn, Peter L Stern

Hum Gene Ther· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma.
Anne C Armstrong, Said Dermime, Kate Mulryan, Peter L Stern, Tapan Bhattacharyya

J Immunother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors.
Kate Mulryan, Matthew G Ryan, Kevin A Myers, David Shaw, Who Wang

Mol Cancer Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
Anne C Armstrong, Said Dermime, Christopher G Allinson, Tapan Bhattacharyya, Kate Mulryan

J Immunol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis